In this section

ICR publications

ICR ImmNet publications feed

Browse all ICR publications

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

01 February 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors.

01 January 2026
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.

31 December 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.

31 December 2025
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.

31 December 2025
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

31 December 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.

22 December 2025
Somatic evolution following cancer treatment in normal tissue.

10 December 2025
Rehydration rescues Il22-/- mice from lethal Citrobacter rodentium infection.

08 December 2025
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.

04 December 2025
Sex-Specific Parent-Offspring Conflict in Humans

01 December 2025
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.

01 December 2025